Continued Use of Trastuzumab Beyond Disease Progression in the National Comprehensive Cancer Network: Should We Practice Ahead of the Evidence?

BACKGROUND. The role of continued trastuzumab after progression in women with human epidermal growth factor receptor (HER)-2(+) metastatic breast cancer is controversial. Controlled clinical trials that establish a benefit from continued trastuzumab have been difficult to complete. METHODS. In the N...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wong, Yu-Ning, Ottesen, Rebecca A., Hughes, Melissa E., Niland, Joyce C., Theriault, Richard, Edge, Stephen B., Blayney, Douglas, Weeks, Jane C.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2011
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228199/
https://ncbi.nlm.nih.gov/pubmed/21450786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0360
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados